DNA診断薬の世界市場レポート 2025年

DNA診断薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.8％で386億4,000万米ドルに成長します。予測期間の成長は、がんの有病率の増加、標準化された診断検査に対する需要の増加、遺伝性疾患の有病率の上昇、バイオマーカー探索、希少疾患、希少疾病治療薬への注目の高まり、遠隔医療と遠隔検査の成長に起因しています。予測期間における主な動向には、マイクロバイオーム解析の統合、ブロックチェーン技術の統合、複数のオミックスデータの統合、非侵襲的検査、マルチオミックスの統合、ポータブルおよびポイントオブケアDNA診断機器の開発、次世代シーケンサー（NGS）などがあります。

遺伝性疾患の罹患率の増加は、当面のDNA診断薬市場の拡大を牽引する構えです。ゲノムの異常に起因する健康上の問題を特徴とする遺伝性疾患は、診断能力の向上、幅広い遺伝子検査の利用可能性、環境の影響、集団内の血縁関係などのいくつかの要因によって増加傾向にあります。これらの要因は総体的に、遺伝性疾患に対する意識の高まりと同定に寄与しています。DNA診断薬は、遺伝物質の分析を通じて遺伝性疾患を正確に特定し、早期診断、オーダーメイドの治療アプローチ、情報に基づいた家族計画の決定を促進する上で重要な役割を果たしています。例えば、2023年2月の世界保健機関（WHO）によると、先天性疾患は世界中で年間約24万人の新生児死亡の原因となっており、さらに17万人が生後1ヶ月から5歳までの小児で死亡しています。その結果、遺伝性疾患の有病率が上昇しており、DNA診断薬市場の成長促進要因となっています。

DNA診断薬分野の主要企業は、様々なタイプのがんを早期に発見するために設計されたリキッドバイオプシー検査などの革新的な製品の開発に力を注いでいます。リキッドバイオプシー検査は、血流中に存在し、腫瘍や他の細胞に由来する循環腫瘍細胞（CTC）、無細胞DNA（cfDNA）、エクソソームなどのバイオマーカーを同定・分析する低侵襲診断アプローチです。例えば、2023年5月、米国の著名なヘルスケア診断会社であるLaboratory Corporationは、LabCorp Plasma Focusと名付けられた新規のリキッドバイオプシー検査を発表しました。この検査は、進行性または転移性の固形腫瘍と診断された患者の標的治療法を特定するために設計されています。LabCorp Plasma Focusは、遺伝子シークエンシング技術を活用し、腫瘍細胞から放出される循環遊離DNA（cfDNA）を評価します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界DNA診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のDNA診断薬市場：成長率分析
• 世界のDNA診断薬市場の実績：規模と成長, 2019-2024
• 世界のDNA診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界DNA診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のDNA診断薬市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬
• ソフトウェアとサービス
• 世界のDNA診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応
• マイクロアレイ
• インサイチューハイブリダイゼーション
• シーケンシング技術
• 質量分析
• 世界のDNA診断薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 感染症治療
• 筋原性疾患の治療
• 臨床診断の確認
• 出生前
• 着床前
• その他の用途
• 世界のDNA診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポイントオブケア
• 診断センター
• 自己検査または市販薬（OTC）
• 世界のDNA診断薬市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAアナライザー
• PCRマシン（ポリメラーゼ連鎖反応）
• シーケンサー（次世代シーケンシング、サンガーシーケンシング）
• 電気泳動システム
• 遺伝子発現アナライザー
• マイクロアレイシステム
• フローサイトメーター
• 分光光度計
• 世界のDNA診断薬市場、試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCR試薬
• DNA抽出キット
• シーケンシング試薬
• DNA検出用抗体
• 蛍光色素とプローブ
• 核酸精製用化学薬品
• DNA分析用緩衝液
• ハイブリダイゼーションおよび増幅キット
• 世界のDNA診断薬市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAデータ分析ソフトウェア
• バイオインフォマティクスプラットフォーム
• シーケンスデータ用のゲノミクスソフトウェア
• 検査情報管理システム（LIMS）
• データ視覚化ツール
• 遺伝子変異解析ソフトウェア
• ゲノムマッピングソフトウェア
• 世界のDNA診断薬市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子検査サービス
• DNAシーケンシングサービス
• バイオインフォマティクスコンサルティングと分析
• 臨床診断サービス
• 遺伝カウンセリングサービス
• カスタムDNA診断薬サービス
• 研究開発サービス

第7章 地域別・国別分析

• 世界のDNA診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のDNA診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• DNA診断薬市場：競合情勢
• DNA診断薬市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton, Dickinson and Company
• Laboratory Corporation
• Quest Diagnostics Incorporated
• Eurofins Scientific SE
• Agilent Technologies
• Illumina Inc
• PerkinElmer Inc
• bioMerieux SA
• Beckman Coulter Inc
• Sysmex Corporation
• Bio-Rad Laboratories Inc
• QIAGEN N.V.
• Natera Inc
• Myriad Genetics Inc.
• BGI Genomics Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• DNA診断薬市場2029：新たな機会を提供する国
• DNA診断薬市場2029：新たな機会を提供するセグメント
• DNA診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

DNA diagnostics involves utilizing genetic testing techniques to examine DNA, RNA, and proteins for medical, forensic, or research purposes. These tests offer valuable insights into genetic predispositions, disease susceptibility, and ancestry, thereby revolutionizing the fields of medicine and genetics and providing effective tools for health management.

DNA diagnostic products encompass instruments, reagents, software, and services. Instruments are specialized equipment used for DNA sample analysis, employing technologies such as polymerase chain reaction, microarray, in-situ hybridization, sequencing, and mass spectrometry. These technologies find applications in diverse areas including oncology, infectious disease treatment, myogenic disorder treatment, clinical diagnostics, prenatal and pre-implantation testing. End users of DNA diagnostic products include point-of-care facilities, diagnostic centers, and individuals seeking self-testing or over-the-counter solutions.

The DNA diagnostics market research report is one of a series of new reports from The Business Research Company that provides DNA diagnostics market statistics, including DNA diagnostics industry global market size, regional shares, competitors with a DNA diagnostics market share, detailed DNA diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the DNA diagnostics industry. This DNA diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The DNA diagnostics market size has grown rapidly in recent years. It will grow from $23.1 billion in 2024 to $25.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of genetic testing and molecular diagnostics in clinical practice, rising biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests.

The DNA diagnostics market size is expected to see rapid growth in the next few years. It will grow to $38.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing the prevalence of cancers, increasing demand for standardized diagnostic tests, rising prevalence of genetic disorders, increasing focus on biomarker discovery, rare diseases and orphan drugs, and growth of telemedicine and remote testing. Major trends in the forecast period include the integration of microbiome analysis, integration of blockchain technology, the integration of multiple omics data, non-invasive testing, multi-omics integration, the development of portable and point-of-care DNA diagnostic devices, and next-generation sequencing (NGS).

The increasing incidence of genetic disorders is poised to drive the expansion of the DNA diagnostics market in the foreseeable future. Genetic disorders, characterized by health issues stemming from abnormalities in the genome, are on the rise due to several factors including enhanced diagnostic capabilities, broader genetic testing availability, environmental influences, and consanguinity within populations. These factors collectively contribute to a heightened awareness and identification of genetic disorders. DNA diagnostics plays a crucial role in precisely identifying genetic disorders through the analysis of genetic material, facilitating early diagnosis, tailored treatment approaches, and informed family planning decisions. For example, according to the World Health Organization (WHO) in February 2023, congenital diseases are responsible for approximately 240,000 neonatal deaths worldwide annually, with an additional 170,000 deaths occurring in children aged between 1 month and 5 years. Consequently, the escalating prevalence of genetic disorders serves as a key driver for the growth of the DNA diagnostics market.

Leading players in the DNA diagnostics sector are directing their efforts towards the development of innovative products, including liquid biopsy tests, designed to detect various types of cancer in their early stages. Liquid biopsy tests represent a minimally invasive diagnostic approach that identifies and analyzes biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), or exosomes, present in the bloodstream and originating from tumors or other cells. For instance, in May 2023, Laboratory Corporation, a prominent US-based healthcare diagnostics company, introduced a novel liquid biopsy test named LabCorp Plasma Focus. This test is designed to identify targeted therapies for patients diagnosed with advanced or metastatic solid tumors. Leveraging genetic sequencing technology, LabCorp Plasma Focus evaluates circulating cell-free DNA (cfDNA) released by tumor cells, enabling oncologists to personalize treatment strategies and enhance patient care through targeted therapy plans.

In November 2022, Myriad Genetics Inc., a leading US-based company specializing in genetic testing and personalized medicine, acquired Gateway Genomics for approximately $67.5 million. This acquisition broadens Myriad's portfolio in women's health and oncology testing, offering patients more comprehensive and personalized genetic testing solutions. Gateway Genomics LLC, the acquired company, specializes in developing prenatal and pediatric genomic tests, aligning with Myriad's commitment to expanding its presence and capabilities in key segments of genetic diagnostics.

Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

North America was the largest region in the DNA diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the DNA diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA diagnostics market consists of revenues earned by entities by providing services such as ancestry testing, paternity or maternity testing, genetic health risk assessment, carrier testing, pharmacogenetic testing, forensic DNA analysis, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA diagnostics market also includes sales of DNA extraction kits, thermal cyclers or polymerase chain reaction machines, DNA sequencers, gel electrophoresis systems, DNA microarrays, automated liquid handling systems, and DNA storage and preservation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
• 2) By Technology: Polymerase Chain Reaction; Microarray; In-situ Hybridization; Sequencing Technology; Mass Spectrometry
• 3) By Application: Oncology; Infectious Diseases Treatment; Myogenic Disorder Treatment; Clinical Diagnostic Confirmation; Prenatal; Pre-Implantation; Other Applications
• 4) By End User: Point Of Care; Diagnostic Centers; Self-Testing Or Over-The-Counter (OTC)

Subsegments

• 1) By Instruments: DNA Analyzers; PCR Machines (Polymerase Chain Reaction); Sequencers (Next-Generation Sequencing, Sanger Sequencing); Electrophoresis Systems; Gene Expression Analyzers; Microarray Systems; Flow Cytometers; Spectrophotometers
• 2) By Reagents: PCR Reagents; DNA Extraction Kits; Sequencing Reagents; Antibodies For DNADetection; Fluorescent Dyes And Probes; Chemicals For Nucleic Acid Purification; Buffer Solutions For DNA Analysis; Hybridization And Amplification Kits
• 3) By Software: DNA Data Analysis Software; Bioinformatics Platforms; Genomics Software For Sequencing Data; Laboratory Information Management Systems (LIMS); Data Visualization Tools; Genetic Variant Analysis Software; Genome Mapping Software
• 4) By Services: Genetic Testing Services; DNA Sequencing Services; Bioinformatics Consulting And Analysis; Clinical Diagnostic Services; Genetic Counseling Services; Custom DNA Diagnostics Services; Research And Development Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA Diagnostics Market Characteristics

3. DNA Diagnostics Market Trends And Strategies

4. DNA Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global DNA Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global DNA Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global DNA Diagnostics Market Growth Rate Analysis
• 5.4. Global DNA Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global DNA Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global DNA Diagnostics Total Addressable Market (TAM)

6. DNA Diagnostics Market Segmentation

• 6.1. Global DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents
• Software And Services
• 6.2. Global DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction
• Microarray
• In-situ Hybridization
• Sequencing Technology
• Mass Spectrometry
• 6.3. Global DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Infectious Diseases Treatment
• Myogenic Disorder Treatment
• Clinical Diagnostic Confirmation
• Prenatal
• Pre-Implantation
• Other Applications
• 6.4. Global DNA Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point Of Care
• Diagnostic Centers
• Self-Testing Or Over-The-Counter (OTC)
• 6.5. Global DNA Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Analyzers
• PCR Machines (Polymerase Chain Reaction)
• Sequencers (Next-Generation Sequencing, Sanger Sequencing)
• Electrophoresis Systems
• Gene Expression Analyzers
• Microarray Systems
• Flow Cytometers
• Spectrophotometers
• 6.6. Global DNA Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Reagents
• DNA Extraction Kits
• Sequencing Reagents
• Antibodies For DNA Detection
• Fluorescent Dyes And Probes
• Chemicals For Nucleic Acid Purification
• Buffer Solutions For DNA Analysis
• Hybridization And Amplification Kits
• 6.7. Global DNA Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Data Analysis Software
• Bioinformatics Platforms
• Genomics Software For Sequencing Data
• Laboratory Information Management Systems (LIMS)
• Data Visualization Tools
• Genetic Variant Analysis Software
• Genome Mapping Software
• 6.8. Global DNA Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing Services
• DNA Sequencing Services
• Bioinformatics Consulting And Analysis
• Clinical Diagnostic Services
• Genetic Counseling Services
• Custom DNA Diagnostics Services
• Research And Development Services

7. DNA Diagnostics Market Regional And Country Analysis

• 7.1. Global DNA Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global DNA Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA Diagnostics Market

• 8.1. Asia-Pacific DNA Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA Diagnostics Market

• 9.1. China DNA Diagnostics Market Overview
• 9.2. China DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA Diagnostics Market

• 10.1. India DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA Diagnostics Market

• 11.1. Japan DNA Diagnostics Market Overview
• 11.2. Japan DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA Diagnostics Market

• 12.1. Australia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA Diagnostics Market

• 13.1. Indonesia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA Diagnostics Market

• 14.1. South Korea DNA Diagnostics Market Overview
• 14.2. South Korea DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA Diagnostics Market

• 15.1. Western Europe DNA Diagnostics Market Overview
• 15.2. Western Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA Diagnostics Market

• 16.1. UK DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA Diagnostics Market

• 17.1. Germany DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA Diagnostics Market

• 18.1. France DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA Diagnostics Market

• 19.1. Italy DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA Diagnostics Market

• 20.1. Spain DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA Diagnostics Market

• 21.1. Eastern Europe DNA Diagnostics Market Overview
• 21.2. Eastern Europe DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA Diagnostics Market

• 22.1. Russia DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA Diagnostics Market

• 23.1. North America DNA Diagnostics Market Overview
• 23.2. North America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA Diagnostics Market

• 24.1. USA DNA Diagnostics Market Overview
• 24.2. USA DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA Diagnostics Market

• 25.1. Canada DNA Diagnostics Market Overview
• 25.2. Canada DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA Diagnostics Market

• 26.1. South America DNA Diagnostics Market Overview
• 26.2. South America DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA Diagnostics Market

• 27.1. Brazil DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA Diagnostics Market

• 28.1. Middle East DNA Diagnostics Market Overview
• 28.2. Middle East DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA Diagnostics Market

• 29.1. Africa DNA Diagnostics Market Overview
• 29.2. Africa DNA Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa DNA Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa DNA Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. DNA Diagnostics Market Competitive Landscape
• 30.2. DNA Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. DNA Diagnostics Market Other Major And Innovative Companies

• 31.1. Becton, Dickinson and Company
• 31.2. Laboratory Corporation
• 31.3. Quest Diagnostics Incorporated
• 31.4. Eurofins Scientific SE
• 31.5. Agilent Technologies
• 31.6. Illumina Inc
• 31.7. PerkinElmer Inc
• 31.8. bioMerieux SA
• 31.9. Beckman Coulter Inc
• 31.10. Sysmex Corporation
• 31.11. Bio-Rad Laboratories Inc
• 31.12. QIAGEN N.V.
• 31.13. Natera Inc
• 31.14. Myriad Genetics Inc.
• 31.15. BGI Genomics Co. Ltd.

32. Global DNA Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA Diagnostics Market

34. Recent Developments In The DNA Diagnostics Market

35. DNA Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 DNA Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 DNA Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 DNA Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer